
Ask a doctor about a prescription for ZARELIS RETARD 37.5 mg PROLONGED-RELEASE TABLETS
Package Leaflet: Information for the User
ZARELIS Retard 37.5 mg prolonged-release tablets
venlafaxine
Contents of the pack and other information
Zarelis Retard contains the active substance venlafaxine.
Venlafaxine is an antidepressant that belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. It is not fully understood how antidepressants work, but they may help to increase the levels of serotonin and norepinephrine in the brain.
Venlafaxine is a treatment for adults with depression. Venlafaxine is also a treatment for adults with the following anxiety disorders: generalized anxiety disorder, social anxiety disorder (fear or avoidance of social situations) and panic disorder (panic attacks). Treating depression and anxiety disorders properly is important to help you feel better. If left untreated, your condition may not improve or may get worse and become more difficult to treat.
Consult your doctor or pharmacist before starting to take this medicine:
Venlafaxine may cause a feeling of restlessness or an inability to sit or stand still during the first few weeks of treatment. You should consult your doctor if this happens to you.
Do not drink alcohol during treatment with venlafaxine, as it may cause extreme fatigue and unconsciousness. Taking it with certain medicines and/or alcohol may worsen symptoms of depression and other conditions, such as anxiety disorders.
If you are depressed and/or have an anxiety disorder, you may sometimes have thoughts of harming yourself or suicide. These thoughts may increase when you first start taking antidepressants, because all these medicines take time to work, usually around two weeks but sometimes longer. These thoughts may also occur when your dose is reduced or when you stop taking venlafaxine.
You may be more likely to think this way:
If you have thoughts of self-harm or suicide at any time, contact your doctor or go to hospital directly.
You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behavior.
Dry mouth
Dry mouth has been reported in 10% of patients treated with venlafaxine. This may increase the risk of dental decay (caries). Therefore, you should be careful with your dental hygiene.
Your blood sugar levels may be altered by venlafaxine. Therefore, it may be necessary to adjust the dose of your diabetes medication.
Sexual problems
Some medicines like venlafaxine (called SNRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Venlafaxine should not normally be used in the treatment of children and adolescents under 18 years of age. Also, you should know that patients under 18 have an increased risk of side effects such as suicide attempts, suicidal thoughts, and hostility (mainly aggression, confrontational behavior, and anger) when they take this class of medicines.
Despite this, your doctor may prescribe this medicine to patients under 18 when they decide that it is the best for the patient. If your doctor has prescribed this medicine to a patient under 18 and you wish to discuss this decision, please consult your doctor again. You should inform your doctor if any of the above symptoms appear or worsen when these patients under 18 are taking venlafaxine. Also, the long-term safety effects of this medicine regarding growth, maturation, and cognitive development in this age group have not been demonstrated.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Your doctor will decide whether you can take venlafaxine with other medicines.
Do not start or stop taking any other medicines, including those that can be bought without a prescription, herbal remedies, and supplements, before consulting your doctor or pharmacist.
A potentially life-threatening condition, or Neuroleptic Malignant Syndrome (NMS), (see section “Possible side effects”), may occur with venlafaxine treatment, particularly when taken with other medicines.
Examples of these medicines include:
The signs and symptoms of serotonin syndrome may include a combination of the following: restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, overactive reflexes, diarrhea, coma, nausea, vomiting.
Serotonin syndrome, in its most severe form, can resemble Neuroleptic Malignant Syndrome (NMS). The symptoms and signs of NMS can include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased levels of muscle enzymes (determined in blood).
Tell your doctor immediately or go to the emergency department of the nearest hospital if you think you are experiencing serotonin syndrome.
You must tell your doctor if you are taking medicines that may affect your heart rhythm.
Examples of these medicines include:
The following medicines may also interact with venlafaxine and should be used with caution. It is especially important to mention to your doctor or pharmacist if you are taking medicines containing:
Venlafaxine should be taken with food (see section 3 “How to take Zarelis Retard”).
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. You should only take venlafaxine after discussing the potential benefits and risks with your doctor.
Make sure your midwife and/or doctor knows you are taking venlafaxine. When you take similar medicines (SSRIs) during pregnancy, it may increase the risk of your baby having a serious condition called persistent pulmonary hypertension of the newborn (PPHN), causing the baby to breathe faster and appear blue. These symptoms usually start during the first 24 hours after birth. If this happens to your baby, you should contact a doctor and/or midwife immediately.
If you take venlafaxine in the final stages of pregnancy, there may be an increased risk of heavy vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking venlafaxine so they can advise you.
If you are taking this medicine during pregnancy, other symptoms your baby may have when born are problems with feeding and problems with breathing. If your baby has these symptoms when born and you are concerned, contact your doctor and/or midwife who can advise you.
Venlafaxine passes into breast milk. There is a risk of an effect on the baby, so you should consult your doctor and they will decide whether you should stop breastfeeding or stop treatment with this medicine.
Driving and using machines
Do not drive or use tools or machines until you know how venlafaxine affects you.
Zarelis Retard contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
The usual recommended starting dose for the treatment of depression, generalized anxiety disorder, and social anxiety disorder is 75 mg per day. Your doctor may gradually increase the dose and, if necessary, increase it up to a maximum of 375 mg per day for depression. If you are being treated for panic disorder, your doctor will start with a lower dose (37.5 mg) and then gradually increase the dose. The maximum dose for generalized anxiety disorder, social anxiety disorder, and panic disorder is 225 mg/day.
Take venlafaxine at approximately the same time each day, either in the morning or in the evening. The tablets should be swallowed whole with liquids and should not be divided, crushed, chewed, or dissolved.
Venlafaxine should be taken with food.
If you have liver or kidney problems, consult your doctor, as you may need a different dose of this medicine.
Do not stop taking venlafaxine without consulting your doctor (see section “If you stop taking Zarelis Retard”).
Contact your doctor or pharmacist immediately if you take more of this medicine than your doctor prescribed.
Overdose can put your life in danger, especially when taken with certain medicines and/or alcohol (see “Other medicines and Zarelis Retard”).
Symptoms of a possible overdose may include palpitations, changes in the level of consciousness (ranging from drowsiness to coma), blurred vision, seizures or fits, and vomiting.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
If you miss a dose, take it as soon as you remember. However, if it is already time for your next dose, skip the missed dose and take only a single dose as usual. Do not take a double dose to make up for forgotten doses. Do not take more than the daily dose of venlafaxine that your doctor has prescribed in one day.
Do not stop taking your treatment or reduce the dose without consulting your doctor, even if you feel better. If your doctor thinks you no longer need venlafaxine, they may ask you to reduce the dose gradually before stopping treatment completely. It is known that side effects occur when people stop using this medicine, especially when it is stopped suddenly or the dose is reduced too quickly. Some patients may experience symptoms such as suicidal thoughts, aggression, fatigue, dizziness, instability, headache, insomnia, nightmares, dry mouth, loss of appetite, nausea, diarrhea, nervousness, agitation, confusion, ringing in the ears, tingling, or, in rare cases, sensations of electric shock, weakness, sweating, seizures, or flu-like symptoms, vision problems, and increased blood pressure (which can cause headache, dizziness, ringing in the ears, sweating, etc.).
Your doctor will advise you on how to gradually stop taking venlafaxine. This may take several weeks or months. In some patients, the discontinuation may need to be done very gradually over periods of several months or more. If you experience any of these or other symptoms that bother you, consult your doctor for further advice.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If any of the following effects occur, do not take more venlafaxine. Inform your doctor immediately, or go to the emergency department of the nearest hospital:
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Serotonin syndrome, in its most severe form, can resemble Neuroleptic Malignant Syndrome (NMS). The symptoms and signs of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased levels of muscle enzymes (determined by a blood test).
Frequency not known (cannot be estimated from the available data)
Other adverse effects that you should report to your doctor include(the frequency of these adverse effects is included in the following list “Other adverse effects that may occur”):
Very Common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 patients)
Very Rare (may affect up to 1 in 10,000 people)
Frequency not known (cannot be estimated from the available data)
Venlafaxine sometimes produces unwanted effects that you may not be aware of, such as increased blood pressure or an abnormal heartbeat; mild changes in blood levels of liver enzymes, sodium, or cholesterol. Less frequently, venlafaxine may reduce the function of blood platelets, leading to an increased risk of bruising or bleeding. Therefore, your doctor may require occasional blood tests, especially if you have been taking venlafaxine for a long time.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the box after “EXP”. The expiration date is the last day of the month indicated.
This medicine does not require any special storage temperature.
Blister: Store in the original packaging to protect it from moisture.
Bottle: Keep the bottle properly closed to protect it from moisture.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines that you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This will help protect the environment.
The active ingredient is venlafaxine.
Each prolonged-release tablet contains 37.5 mg of venlafaxine (as hydrochloride).
The other ingredients (excipients) are:
The 37.5 mg prolonged-release tablets are 7 mm, round, biconvex, and white.
Zarelis Retard 37.5 mg is available in blisters of 10, 14, 20, 28, 30, 50, 56, 60, 100, and 500 tablets; and in plastic bottles of 10, 14, 20, 28, 30, 50, 56, 60, 100, and 500 tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
ITALFARMACO, S.A.
San Rafael, 3 – 28108 Alcobendas (Madrid),
Spain
Manufacturer:
LICONSA Laboratories, S.A.
Miralcampo Avenue, No. 7, Miralcampo Industrial Estate
19200 Azuqueca de Henares (Guadalajara),
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Member State | Medicine Name |
Sweden | Venlafaxine Liconsa 37.5 mg prolonged-release tablets |
Spain | Zarelis retard 37.5 mg prolonged-release tablets |
Finland | Venlafaxine Sandoz 37.5 mg prolonged-release tablets |
Germany | Venlafaxine AAA-Pharma 37.5 mg prolonged-release tablets |
Date of the last revision of this leaflet:February 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
Other Sources of Information
Detailed information about this medicine is available on the website of the European Medicines Agency: https://www.ema.europa.eu
The average price of ZARELIS RETARD 37.5 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 4.79 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ZARELIS RETARD 37.5 mg PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.